Clinical-grade natural killer cells expanded from donor peripheral blood and anti-leukemia effect against myeloid leukemia

被引：0
|
作者：
Zhao, Xiang-Yu
Jiang, Hao
Jiang, Qian
Cao, Xun-Hong
Fang, Fang
Xie, Siqi
Fu, Yongling
Zhang, Cai
Xiao, Weihua
Tian, Zhigang
Huang, Xiao-Jun
机构：
[1] Beijing Key Lab Hematopoiet Stem Cell Transplanta, Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing, Peoples R China
[2] Univ Sci & Technol China, Inst Immunol, Sch Basic Med Sci, Div Life Sci & Med, Hefei, Peoples R China
[3] Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med, CAS Key Lab Innate Immun & Chron Dis, Hefei, Peoples R China
[4] Shanghai NK CellTech Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19018
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The effect of hypoxia on the natural killer activity of human peripheral blood lymphocytes against cancer cells
    Siemens, D. Robert
    Sheikhi, Abdol-Karim
    Chung, Eugene
    Pross, Hugh
    Graham, Charles H.
    CANCER RESEARCH, 2006, 66 (08)
  • [42] Chimeric Cytokine Receptors Induce Antigen-Specific Activation in Natural Killer Cells Against Acute Myeloid Leukemia
    Holl, Natalie J.
    Rahnama, Ruyan
    Choe, Jun
    Zinsky, Megan
    Jones, Danielle Grace
    Bonifant, Challice L.
    MOLECULAR THERAPY, 2024, 32 (04) : 50 - 51
  • [43] Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
    Romee, Rizwan
    Rosario, Maximillian
    Berrien-Elliott, Melissa M.
    Wagner, Julia A.
    Jewell, Brea A.
    Schappe, Timothy
    Leong, Jeffrey W.
    Abdel-Latif, Sara
    Schneider, Stephanie E.
    Willey, Sarah
    Neal, Carly C.
    Yu, Liyang
    Oh, Stephen T.
    Lee, Yi-Shan
    Mulder, Arend
    Claas, Frans
    Cooper, Megan A.
    Fehniger, Todd A.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (357)
  • [44] EX VIVO GENERATION OF CLINICALLY RELEVANT AMOUNTS OF HUMAN NATURAL KILLER CELLS FOR IMMUNOTHERAPY AGAINST ACUTE MYELOID LEUKEMIA
    Spanholtz, J.
    Tordoir, M.
    De Witte, T.
    Dolstra, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 240 - 240
  • [45] A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Universally Alloreactive Donor-Derived Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Vasu, Sumithira
    Sharma, Nidhi
    Walker, Alison R.
    Wall, Sarah A.
    Blachly, James S.
    Behbehani, Greg K.
    Choe, Hannah
    Thakkar, Aarohi
    Nakkula, Robin
    Troy, Ella
    Szuminski, Nicole
    de Lima, Marcos J. G.
    O'Donnell, Lynn
    Lee, Dean Anthony
    BLOOD, 2021, 138
  • [46] ISOLATION OF MYELOID PROGENITOR CELLS FROM PERIPHERAL-BLOOD OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
    GRIFFIN, JD
    BEVERIDGE, RP
    SCHLOSSMAN, SF
    BLOOD, 1982, 60 (01) : 30 - 37
  • [47] Generation of dendritic cells from peripheral blood of patients at different stages of chronic myeloid leukemia
    Zheng, C
    Pisa, P
    Stromberg, O
    Blennow, E
    Hansson, M
    MEDICAL ONCOLOGY, 2000, 17 (04) : 270 - 278
  • [48] Generation of dendritic cells from peripheral blood of patients at different stages of chronic myeloid leukemia
    C Zheng
    P Pisa
    O Stromberg
    E Blennow
    M Hansson
    Medical Oncology, 2000, 17 : 270 - 278
  • [49] Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy
    S Merims
    X Li
    B Joe
    P Dokouhaki
    M Han
    R W Childs
    Z-Y Wang
    V Gupta
    M D Minden
    L Zhang
    Leukemia, 2011, 25 : 1415 - 1422
  • [50] Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways
    Zhao, Mu-Nan
    Su, Long
    Song, Fei
    Wei, Zhi-Feng
    Qin, Tian-Xue
    Zhang, Yun-Wei
    Li, Wei
    Gao, Su-Jun
    ACTA HAEMATOLOGICA, 2023, : 310 - 323
12345